Provided by Tiger Trade Technology Pte. Ltd.

Carlisle

321.25
+3.030.95%
Pre-market: 323.752.50+0.78%06:52 EDT
Volume:477.79K
Turnover:152.80M
Market Cap:12.76B
PE:18.47
High:323.23
Open:315.00
Low:312.55
Close:318.22
52wk High:432.91
52wk Low:293.43
Shares:39.71M
Float Shares:39.20M
Volume Ratio:1.06
T/O Rate:1.22%
Dividend:4.40
Dividend Rate:1.37%
EPS(TTM):17.39
EPS(LYR):17.12
ROE:39.18%
ROA:10.81%
PB:7.89
PE(LYR):18.77

Loading ...

Australia R&D Changes Look Positive for CSL, Others -- Market Talk

Dow Jones
·
May 13

Analysts Conflicted on These Healthcare Names: CSL (OtherCMXHF) and Tilray (TLRY)

TIPRANKS
·
May 12

Ord Minnett Keeps Their Hold Rating on CSL (CMXHF)

TIPRANKS
·
May 12

Morgan Stanley Reaffirms Their Buy Rating on CSL (CMXHF)

TIPRANKS
·
May 12

CSL (CMXHF) Receives a Hold from Bell Potter

TIPRANKS
·
May 12

CSL's Revenue, Profit Guidance Downgrade Worse Than Anticipated -- Market Talk

Dow Jones
·
May 12

CSL's Profit, Revenue Downgrade 'Not a Complete Surprise' -- Market Talk

Dow Jones
·
May 12

CSL downgraded to Neutral from Buy at Citi

TIPRANKS
·
May 12

Australian Shares Retreat; CSL Cuts Fiscal Year 2026 Outlook, Flags $5 Billion of Additional Impairments

MT Newswires Live
·
May 11

Macquarie Sticks to Their Hold Rating for CSL (CMXHF)

TIPRANKS
·
May 11

CSL on Track for Lowest Close Since 2017 Following Profit Warning -- Market Talk

Dow Jones
·
May 11

CSL Cuts Fiscal 2026 Outlook, Flags $5 Billion of Additional Impairments; Shares Hit Nine-Year Low

MT Newswires Live
·
May 11

CSL Cuts Annual Guidance, Signals $5 Billion of New Impairments -- Update

Dow Jones
·
May 11

CSL Cuts FY26 Guidance After Interim CEO’s 90-Day Review

TIPRANKS
·
May 11

How CSL’s Share Buyback and Seqirus Demerger Plan Will Impact CSL (ASX:CSL) Investors

Simply Wall St.
·
May 10

A Look At CSL (ASX:CSL) Valuation After Seqirus Demerger Plan CEO Exit And Ongoing Share Price Weakness

Simply Wall St.
·
May 09

CSL (CMXHF) Receives a Buy from UBS

TIPRANKS
·
May 08

Carlisle price target lowered to $43 from $44 at Baird

TIPRANKS
·
May 08

CSL Completes $1.06 Billion On‑Market Share Buy‑Back

TIPRANKS
·
May 05

Market Chatter: CSL, Resmed, Cochlear Lead Losses on ASX

MT Newswires Live
·
May 04